Anticorpi Bag3

14 prodotti

Bag3 è un gene codificato dal simbolo BAG3. Altri nomi includono: BAG family molecular chaperone regulator 3; BAG-3; Bcl-2-associated athanogene 3; Bcl-2-binding protein Bis; Docking protein CAIR-1; BIS. Bag3 ha una massa di 61.6kDa, una lunghezza di amminoacidi di 575, ed è implicato nella malattia: Myopathy, myofibrillar, 6; Cardiomyopathy, dilated 1HH.

Offriamo 14 anticorpi contro Bag3, allevati nel Coniglio e Capra, che sono adatti per WB, IHC, ELISA, ICC/IF e IP con campioni derivati ​​da Umano, Topo e Ratto.

Informazioni su geni e proteine

Riepilogo UniProt
Co-chaperone for HSP70 and HSC70 chaperone proteins. Acts as a nucleotide-exchange factor (NEF) promoting the release of ADP from the HSP70 and HSC70 proteins thereby triggering client/substrate protein release. Nucleotide release is mediated via its binding to the nucleotide-binding domain (NBD) of HSPA8/HSC70 where as the substrate release is mediated via its binding to the substrate-binding domain (SBD) of HSPA8/HSC70 (PubMed:9873016, PubMed:27474739). Has anti-apoptotic activity (PubMed:10597216). Plays a role in the HSF1 nucleocytoplasmic transport (PubMed:26159920).
Sommario di Entrez
BAG proteins compete with Hip for binding to the Hsc70/Hsp70 ATPase domain and promote substrate release. All the BAG proteins have an approximately 45-amino acid BAG domain near the C terminus but differ markedly in their N-terminal regions. The protein encoded by this gene contains a WW domain in the N-terminal region and a BAG domain in the C-terminal region. The BAG domains of BAG1, BAG2, and BAG3 interact specifically with the Hsc70 ATPase domain in vitro and in mammalian cells. All 3 proteins bind with high affinity to the ATPase domain of Hsc70 and inhibit its chaperone activity in a Hip-repressible manner.
Coinvolgimento nella malattia
Myopathy, myofibrillar, 6: A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM6 is characterized by early-onset of severe, progressive, diffuse muscle weakness associated with cardiomyopathy, severe respiratory insufficiency during adolescence, and a rigid spine in some patients.

Cardiomyopathy, dilated 1HH: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
Posizione cellulare
Nucleus. Cytoplasm.

Colocalizes with HSF1 to the nucleus upon heat stress (PubMed:26159920).
Collegamenti al database
Western Blot - Anti-Bag3 Antibody (A91265) - Antibodies.com
(4)
Western Blot - Anti-BAG3 Antibody (R12-2533) - Antibodies.com
Visualizza prodotto10µg Dimensione di prova
Western Blot - Anti-BAG3 Antibody (A83851) - Antibodies.com
(4)
Western Blot - Anti-BAG3 Antibody (A84412) - Antibodies.com
(2)
Western Blot - Anti-BAG3 Antibody (C30035) - Antibodies.com
(3)
Visualizza prodotto10µg Dimensione di prova
Western Blot - Anti-Bag3 Antibody [ARC1104] (A308026) - Antibodies.com
(2)
Segnaposto immagine Antibodies.com - Scopri di più spendendo meno
Visualizza prodotto10µg Dimensione di prova
BAG3 Antibody from Signalway Antibody (35593) - Antibodies.com
(2)
Western blot - BAG3 (Phospho-Tyr457) Antibody from Signalway Antibody (12575) - Antibodies.com
Western blot - BAG3 Antibody from Signalway Antibody (35276) - Antibodies.com
(2)
Anti-Bag-3 Antibody from Bioworld Technology (BS60002) - Antibodies.com
Western blot - Bag-3 Polyclonal Antibody from Signalway Antibody (41910) - Antibodies.com
BAG3 Antibody from Signalway Antibody (35389) - Antibodies.com
Bis (5'-adenosyl)-triphosphatase Polyclonal Antibody from Signalway Antibody (42542) - Antibodies.com

Mostra 1-14 di 14 prodotti

Filtri Menù Principale Contattaci 0Check-out
Inizio pagina